Remove Biotech Remove Capital Remove Value Chain
article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. Global Healthcare Capital Markets Activity. Healthcare Funding – Normalization of ‘Cash Runways’.

Capital 98
article thumbnail

Top Expert Network Companies in 2023 (Buyer’s Guide)

Alpha Sense BI

Third Bridge also recognizes that value chain information is typically fragmented, unqualified, and outdated. Maps solve this problem by visually presenting public and private company value chains in a single view, helping investors fast-track early-stage research within minutes, not days.